Cholestatic Jaundice in Sulphite Oxidase Deficiency - An Unusual Association
- PMID: 32648099
- DOI: 10.1007/s12098-020-03428-3
Cholestatic Jaundice in Sulphite Oxidase Deficiency - An Unusual Association
Abstract
Sulphite oxidase deficiency is an extremely rare inborn error of metabolism of sulphur containing amino acids. There are no reports of liver involvement in this condition. The authors describe a 9-y-old boy with known sulphite oxidase deficiency who presented with worsening cholestatic hepatitis which may be possibly related to underlying metabolic disorder. Although there is no current evidence that treating liver disease and ensuring normal hepatic function in sulphite oxidase deficiency would likely benefit patients, this could potentially contribute to optimising growth and development as well as improving the overall prognosis.
Keywords: Cholestatic hepatitis; Metabolic disorder; Pediatric; Sulphite oxidase deficiency.
Comment in
-
Cholestatic Jaundice in Sulphite Oxidase Deficiency - An Unusual Association: Correspondence.Indian J Pediatr. 2021 Jun;88(6):628-629. doi: 10.1007/s12098-020-03560-0. Epub 2020 Nov 18. Indian J Pediatr. 2021. PMID: 33205359 No abstract available.
References
-
- Bindu PS, Nagappa M, Bharath RD, Taly AB. Isolated sulfite oxidase deficiency. 2017 Sep 21. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. Available at: https://www.ncbi.nlm.nih.gov/books/NBK453433/
-
- Johnson JL, Duran M. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease, Vol 2. 8th ed. New York: McGraw-Hill; 2001. p. 3163–77.
-
- Cabrera D, Arab JP, Arrese M. UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications. In: Fiorucci S, Distrutti E, editors. Handbook of experimental pharmacology, bile acids and their receptors, vol. 256. Berlin: Springer-Verlag; 2019. p. 237–64.
-
- Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36:525–31. - DOI
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical